Senior insider sale
PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$21.67M
316.57K shares
TORLEY HELEN plans to sell 316.57K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $21.67M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2025 | Stock Option Exercise Cash | 136.57K | — |
| Total | 136.57K | ||
Completed
Units to sell
20K
Market value
$1.48M
Units to sell
20K
Market value
$1.49M
Units to sell
20K
Market value
$1.48M
Units to sell
20K
Market value
$1.29M
Units to sell
20K
Market value
$1.27M
Units to sell
20K
Market value
$1.26M
Units to sell
20K
Market value
$1.15M
Units to sell
20K
Market value
$1.13M
Units to sell
20K
Market value
$1.11M
Planned — Approximate Date
Units to sell
136.57K
Market value
$10.02M
Units
316.57K
Value
$21.67M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/4/2025 | 20K | $1.48M | — | Completed |
9/3/2025 | 20K | $1.49M | — | Completed |
9/2/2025 | 20K | $1.48M | — | Completed |
8/13/2025 | 20K | $1.29M | — | Completed |
8/12/2025 | 20K | $1.27M | — | Completed |
8/11/2025 | 20K | $1.26M | — | Completed |
7/10/2025 | 20K | $1.15M | — | Completed |
7/9/2025 | 20K | $1.13M | — | Completed |
7/8/2025 | 20K | $1.11M | — | Completed |
| Planned — Approximate Date | ||||
10/1/2025 | 136.57K | $10.02M | NASDAQ | Planned |
| Total | 316.57K | $21.67M | ||